This inventor holds 1 USPTO granted patent. Top assignee: Cadila Healthcare Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Ranjeet Nair: Innovator in Quinolone Based Compounds
Introduction
Ranjeet Nair is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of quinolone based compounds. His innovative work has the potential to impact the treatment of anemia, showcasing his dedication to improving healthcare.
Latest Patents
Ranjeet Nair holds a patent for a process for the preparation of quinolone based compounds. This invention relates to an improved method for synthesizing these compounds using intermediate compounds. The process not only enhances the efficiency of production but also addresses the generation of novel impurities during the synthesis. The compounds produced through this method can be utilized in treating anemia, highlighting their therapeutic significance.
Career Highlights
Ranjeet Nair is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His role in the company allows him to leverage his expertise in drug development and contribute to innovative healthcare solutions. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Ranjeet collaborates with talented professionals in his field, including Vivek Joshi and Rajiv Sharma. These collaborations foster a creative environment that encourages the exchange of ideas and enhances the development of innovative solutions.
Conclusion
Ranjeet Nair's contributions to the field of pharmaceuticals, particularly through his patent on quinolone based compounds, demonstrate his commitment to innovation and healthcare improvement. His work at Cadila Healthcare Limited and collaborations with fellow professionals further underscore his impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
